Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation.
Saved in:
| Title: | Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation. |
|---|---|
| Authors: | Carrasco M; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain., Guzman L; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain., Barroso E; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Institute of Biomedicine of the University of Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain., Olloquequi J; Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Institute of Biomedical Sciences, Faculty of Health Sciences, Universidad Autónoma de Chile, Talca, Chile., Cano A; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain., Ureña J; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028, Barcelona, Spain., Verdaguer E; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028, Barcelona, Spain., Prohens R; Laboratory of Organic Chemistry, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Avda. Joan XXIII, 08028, Barcelona, Spain.; Center for Intelligent Research in Crystal Engineering S.L., Parc Científic de Barcelona, Baldiri Reixac, 4-8, 08028, Barcelona, Spain., Fortuna A; Laboratory of Pharmacology and Pharmaceutical Care, Faculty of Pharmacy, University of Coimbra, 3000-548, Coimbra, Portugal.; Coimbra Institute for Biomedical Imaging and Translational Research, CIBIT/ICNAS, University of Coimbra, 3000-548, Coimbra, Portugal., Auladell C; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028, Barcelona, Spain., Ettcheto M; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain. mirenettcheto@ub.edu.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. mirenettcheto@ub.edu.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain. mirenettcheto@ub.edu.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. mirenettcheto@ub.edu., Camins A; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. |
| Source: | GeroScience [Geroscience] 2026 Jun 06. Date of Electronic Publication: 2026 Jun 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101686284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-2723 (Electronic) Linking ISSN: 25092723 NLM ISO Abbreviation: Geroscience Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42250112 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Carrasco+M%22">Carrasco M</searchLink>; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.<br /><searchLink fieldCode="AU" term="%22Guzman+L%22">Guzman L</searchLink>; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Barroso+E%22">Barroso E</searchLink>; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Institute of Biomedicine of the University of Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Olloquequi+J%22">Olloquequi J</searchLink>; Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Institute of Biomedical Sciences, Faculty of Health Sciences, Universidad Autónoma de Chile, Talca, Chile.<br /><searchLink fieldCode="AU" term="%22Cano+A%22">Cano A</searchLink>; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ureña+J%22">Ureña J</searchLink>; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Verdaguer+E%22">Verdaguer E</searchLink>; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Prohens+R%22">Prohens R</searchLink>; Laboratory of Organic Chemistry, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Avda. Joan XXIII, 08028, Barcelona, Spain.; Center for Intelligent Research in Crystal Engineering S.L., Parc Científic de Barcelona, Baldiri Reixac, 4-8, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Fortuna+A%22">Fortuna A</searchLink>; Laboratory of Pharmacology and Pharmaceutical Care, Faculty of Pharmacy, University of Coimbra, 3000-548, Coimbra, Portugal.; Coimbra Institute for Biomedical Imaging and Translational Research, CIBIT/ICNAS, University of Coimbra, 3000-548, Coimbra, Portugal.<br /><searchLink fieldCode="AU" term="%22Auladell+C%22">Auladell C</searchLink>; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Department of Cellular Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ettcheto+M%22">Ettcheto M</searchLink>; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain. mirenettcheto@ub.edu.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain. mirenettcheto@ub.edu.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain. mirenettcheto@ub.edu.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. mirenettcheto@ub.edu.<br /><searchLink fieldCode="AU" term="%22Camins+A%22">Camins A</searchLink>; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, 08028, Barcelona, Spain.; Biomedical Research Networking Center in Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Institute of Neuroscience, Universitat de Barcelona, Barcelona, Spain.; Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101686284%22">GeroScience</searchLink> [Geroscience] 2026 Jun 06. <i>Date of Electronic Publication: </i>2026 Jun 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101686284 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2509-2723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225092723%22">25092723 </searchLink><i>NLM ISO Abbreviation: </i>Geroscience <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42250112 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11357-026-02321-9 Languages: – Code: eng Text: English Titles: – TitleFull: Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Carrasco M – PersonEntity: Name: NameFull: Guzman L – PersonEntity: Name: NameFull: Barroso E – PersonEntity: Name: NameFull: Olloquequi J – PersonEntity: Name: NameFull: Cano A – PersonEntity: Name: NameFull: Ureña J – PersonEntity: Name: NameFull: Verdaguer E – PersonEntity: Name: NameFull: Prohens R – PersonEntity: Name: NameFull: Fortuna A – PersonEntity: Name: NameFull: Auladell C – PersonEntity: Name: NameFull: Ettcheto M – PersonEntity: Name: NameFull: Camins A IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 06 Text: 2026 Jun 06 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2509-2723 Titles: – TitleFull: GeroScience Type: main |
| ResultId | 1 |